2018
A documentary exploring plant medicines and psychedelics, with an attempt to show a different perspective than the current mainstream narrative. Some of them used for thousands of years as ...
84 min
CLEAR ALL
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
1
Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.
In this edited version of Roland Griffith’s very information talk on Psilocybin (original title “The science of psilocybin and its use to relieve suffering”) we take a look at the amazing positive effects achieved with this controversial substance.
This presentation summarizes past and ongoing studies from the Johns Hopkins Psilocybin Research Project, which started about 15 years ago.
Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.
Bestselling author Tim Ferriss (Tools of Titans, The 4-Hour Workweek, etc.) probes the science, mysteries, and future of psychedelics with Dr. Roland R. Griffiths, a clinical pharmacologist at Johns Hopkins. Dr.
Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.
Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.
Exploring the bright future of psychedelics, Thomas B. Roberts, Ph.D., reveals how new uses for entheogens will enrich individuals as well as society as a whole. With contributions from Charles Grob, M.D., and Roger N. Walsh, M.D., Ph.D.